Ticker Details
BridgeBio Pharma, Inc.
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$13.54B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.91 | 3.00%
Avg Daily Range (30 D):	$1.91 | 2.61%
Avg Daily Range (90 D):	$1.80 | 2.47%

Institutional Daily Volume
Avg Daily Volume:	1.51M
Avg Daily Volume (30 D):	2.4M
Avg Daily Volume (90 D):	2.33M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	8,570
Avg Institutional Trade:	$3.37M
Avg Institutional Trade (30 D):	$4.37M
Avg Institutional Trade (90 D):	$4.49M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$8.08M
Avg Closing Trade (30 D):	$17.88M
Avg Closing Trade (90 D):	$20.21M
Avg Closing Volume:	249.79K

News

May 12, 2026 @ 12:30 PM Wall Street's Cardiac Bet: Where Diagnostics Meet ... Source: Usa News Group

Mar 30, 2026 @ 7:30 PM Acoramidis Significantly Reduces the Risk of All-C... Source: Bridgebio Pharma, Inc.

Mar 11, 2026 @ 6:00 PM BBP-418 Demonstrates Consistent Efficacy and Favor... Source: Bridgebio Pharma, Inc.

Mar 10, 2026 @ 6:49 PM BridgeBio's Rare-Disease Pipeline Sparks Growth Bu... Source: Vandana Singh

Feb 22, 2026 @ 3:00 PM Blue Owl, Genuine Parts, And Okta Are Among Top 10... Source: Nabaparna Bhattacharya

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.73	$-.84
Diluted EPS	$-3.73	$-.84
Revenue	$579.96M	$194.52M
Gross Profit	$551.7M	$184.58M
Net Income / Loss	$-729.89M	$-166.56M
Operating Income / Loss	$-525M	$-105.96M
Cost of Revenue	$28.26M	$9.94M
Net Cash Flow	$339.28M	$309.88M
PE Ratio